Effect of life-style on temporomandibular joint disorders

Evaluation of the effect of life-style factors on temporomandibular disorders

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210209050304N1

Enrollment

Registered

2021-07-29

Start date

2021-07-23

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular joint disorder. Temporomandibular joint disorders

Interventions

Intervention 1: Control group: They receive the routine pharmacotherapy regimen (Naproxen 250mg q8h AND Methocarbamol 500mg q8h for 2 weeks). Intervention 2: Intervention group: In addition to pharmac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Temporomandibular disorder (TMD) signs and symptoms Patients suffering from sleep disturbance Patients suffering from psychological distress

Exclusion criteria

Exclusion criteria: Patients suffering from systemic diseases that affects the temporomandibular joint History of jaw fracture or trauma History of orthognathic surgery or other joint surgeries Patients who have an acceptable life-style

Design outcomes

Primary

Measure	Time frame
Joint pain. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Visual Analogue Scale.;Clicking. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Clinical examination.;Maximum Mouth Opening. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Clinical Examination.;Crepitus. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Clinical Examination.;Stress Score according to Psychological General Well-Being Index. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Psychological General Well-Being Index.;Sleep quality according to The Pittsburgh Sleep Quality Index. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: The Pittsburgh Sleep Quality Index Questinnaire.	—

Measure

Time frame

Joint pain. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Visual Analogue Scale.;Clicking. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Clinical examination.;Maximum Mouth Opening. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Clinical Examination.;Crepitus. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Clinical Examination.;Stress Score according to Psychological General Well-Being Index. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: Psychological General Well-Being Index.;Sleep quality according to The Pittsburgh Sleep Quality Index. Timepoint: At the beginning of the trial and on the follow up sessions; 3, 6 and 9 months after starting the intervention. Method of measurement: The Pittsburgh Sleep Quality Index Questinnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Tabrizi

Shahid Beheshti University of Medical Sciences

tabmed@gmail.com+98 21 2267 2126

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026